gemcitabine-nabpaclitaxelliposomal irinotecanNALIRIfluorouracilfolinic acidMetastatic pancreatic cancerNAPOLI-1 trialmPC
…nd lymph node (9%). In metastatic disease, 40 patients received gemcitabine-nabpaclitaxel as first-line treatment. Seventy-two percent of patients receiv…